Mitchell Gold

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Seattle, WA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ James Paul Rickey, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mitchell Gold

Form 4 holding Executive Chairman and CEO, Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
18 May 2024
Price
$6.33
Ownership
Alpine ImmunoSciences, L.P.
Form 4 holding Executive Chairman and CEO, Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
20 May 2024
Price
$6.33
Ownership
Direct
Form 4 holding Executive Chairman and CEO, Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Stock Option (Right to buy)
Shares / value
0
Estimated value
Report date
20 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Chairman and CEO, Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Warrant (right to buy)
Shares / value
0
Estimated value
Report date
28 Dec 2023
Price
Ownership
Alpine ImmunoSciences, L.P.
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mitchell Gold

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .